This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Array Biopharma Inc.. Active years: 2006-2007.
Company Filing History:
Years Active: 2006-2007
Title: Brian Hurley: Innovator in MEK Inhibitors
Introduction
Brian Hurley is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of MEK inhibitors. With a total of 2 patents to his name, Hurley is recognized for his innovative approaches to treating hyperproliferative diseases.
Latest Patents
Hurley's latest patents focus on heterocyclic inhibitors of MEK and their methods of use. These patents disclose compounds that are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. The compounds are defined by specific formulas and include pharmaceutically acceptable salts and prodrugs. The methods outlined in these patents detail how these compounds can be utilized in pharmaceutical compositions for effective treatment.
Career Highlights
Brian Hurley is currently associated with Array Biopharma Inc., where he continues to advance his research and development efforts. His work has been instrumental in the creation of innovative therapies aimed at combating serious health conditions.
Collaborations
Throughout his career, Hurley has collaborated with esteemed colleagues, including Joseph P. Lyssikatos and Jim Blake. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking treatments.
Conclusion
Brian Hurley stands out as a key figure in the field of pharmaceutical innovation, particularly with his work on MEK inhibitors. His contributions are paving the way for new treatment options for serious diseases.